Research programme: cancer therapeutics - Pivot PharmaceuticalsAlternative Names: PVT 005; PVT 006
Latest Information Update: 10 May 2016
At a glance
- Originator IndUS Pharmaceuticals
- Developer Pivot Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer; Endometrial cancer
Most Recent Events
- 30 Dec 2015 Preclinical trials in Breast cancer in USA (unspecified route)
- 30 Dec 2015 Preclinical trials in Endometrial cancer in USA (unspecified route)